Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida’s KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida’s KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Feb 22 2023

Full Issue

Study Highlights High Fatality Of Mpox For People With Advanced HIV

News outlets cover the results of the first major study of mpox among people with advanced cases of HIV, showing it often causes severe illness and has a high death rate. Among other news, a study finds Hispanic and Black veterans are having to wait longer to see health specialists.

NBC News: Mpox Is Highly Fatal Among People With Advanced HIV, Study Finds

Mpox can have a devastating impact on people with advanced cases of HIV, leading to severe skin and genital lesions and causing death in as many as 1 in 4 of those with a highly compromised immune system. This is according to the first major study of mpox in this population, which a global team of authors published in The Lancet on Tuesday. The analysis included 382 people from 28 nations, all of whom were HIV-positive and had a count below 350 of key immune cells called CD4 cells, which help ward off infections. Twenty-seven of these individuals died. (Ryan, 2/21)

The New York Times: Mpox Often Leads To Severe Illness, Even Death, In People With Advanced H.I.V.

In people with advanced H.I.V. disease, the mpox virus — formerly known as monkeypox — often causes severe illness, with a death rate of about 15 percent, researchers reported on Tuesday. The seriousness of the infection warrants the inclusion of mpox among the opportunistic conditions that are particularly dangerous to people with advanced H.I.V., the researchers said at the Conference on Retroviruses and Opportunistic Infections in Seattle. (Mandavilli, 2/21)

Meanwhile, in other research news —

Noticias Telemundo for Axios: Study Finds Hispanic Veterans Wait Longer For Specialists

Black and Hispanic veterans' access to specialty health care declined during the pandemic, according to a recently published study that also found non-Hispanic white veterans were largely unaffected. About 12% of vets are Black and 8% are Latino. Those numbers are projected to grow to 15% and 12% respectively by 2045, according to the Department of Veterans Affairs. (Franco, 2/21)

St. Louis Public Radio: Wash U Study Links Depression In Black College Grads To Racism

Researchers from the Brown School at Washington University in St. Louis found that college-educated Black Americans are suffering racial discrimination that leads to depression. For “Understanding the Impact of Contemporary Racism on the Mental Health of Middle Class Black Americans”, researchers conducted a nationwide online survey of 528 college graduates over 24 years old to determine if there is a health cost to being a college-educated Black American. (Henderson, 2/17)

CIDRAP: Trial Finds Prophylactic Doxycycline Doesn’t Reduce STIs In Cisgender Women

A clinical trial in Kenya found that taking the antibiotic doxycycline after sex did not prevent sexually transmitted infections (STIs) in cisgender women, researchers reported at this week's Conference on Retroviruses and Opportunistic Infections (CROI). (Dall, 2/21)

On research relating to covid —

CIDRAP: Brain Changes May Be Linked To Anxiety, Depression In Long COVID

People who have long COVID and experience anxiety and depression following a mild infection may have brain changes that affect its structure and function, Brazilian researchers reported yesterday at the American Academy of Neurology (AAN) annual meeting in Boston. (Schnirring, 2/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF